The development of pre-clinical models to study and identify novel biomarkers in muscle invasive bladder cancer
Bladder cancer is the 4th commonest malignancy in the United Kingdom and worldwide there are nearly 400,000 new cases every year with over 150,000 deaths. The gold standard treatment for muscle invasive bladder cancer is radical cystectomy with neoadjuvant chemotherapy. Despite this the overall surv...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Southampton
2015
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.729610 |